How do you manage Xanax (alprazolam) dependency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Managing Xanax (alprazolam) dependency requires a gradual tapering approach under medical supervision rather than abrupt discontinuation, with the goal of minimizing withdrawal symptoms and reducing the risk of dangerous complications, as supported by the most recent and highest quality study 1.

Key Considerations

  • The tapering process should be individualized, taking into account the patient's medical history, current dose, and motivation to quit.
  • A commonly used tapering schedule is a reduction of the benzodiazepine dose by 25% every 1–2 weeks, as suggested by 1.
  • Patients should be monitored for withdrawal symptoms, including anxiety, insomnia, irritability, tremors, and in severe cases, seizures.
  • Adjunctive treatments, such as cognitive behavioral therapy, support groups, and temporary use of medications like hydroxyzine, propranolol, or clonidine, may be necessary to manage specific withdrawal symptoms.

Tapering Approach

  • The recommended approach is to reduce the dose by 10-25% every 1-2 weeks, with slower reductions as the dose gets lower.
  • For example, someone taking 2mg daily might reduce to 1.5mg for two weeks, then 1mg for two weeks, and continue this pattern with smaller reductions (0.75mg, 0.5mg, 0.25mg, 0.125mg) until completely off the medication.
  • Some physicians may switch patients to a longer-acting benzodiazepine like diazepam (Valium) for easier tapering, as mentioned in 1.

Importance of Medical Supervision

  • Medical supervision is crucial to ensure a safe and successful tapering process.
  • Patients should be closely monitored for withdrawal symptoms and adjusted tapering schedules as needed.
  • The EMPOWER trial, mentioned in 1, demonstrated the importance of education and patient ownership in successful benzodiazepine tapering.

Additional Considerations

  • The use of nonpharmacological interventions, such as cognitive behavioral therapy and support groups, can increase tapering success rates, as noted in 1.
  • Clinicians should communicate with mental health professionals managing the patient to discuss the patient’s needs, prioritize patient goals, and coordinate care, as emphasized in 1.

From the FDA Drug Label

DRUG ABUSE AND DEPENDENCE Physical and Psychological Dependence Withdrawal symptoms similar in character to those noted with sedative/hypnotics and alcohol have occurred following discontinuance of benzodiazepines, including alprazolam tablets The symptoms can range from mild dysphoria and insomnia to a major syndrome that may include abdominal and muscle cramps, vomiting, sweating, tremors and convulsions. It is recommended that all patients on alprazolam tablets who require a dosage reduction be gradually tapered under close supervision (see WARNINGS and DOSAGE AND ADMINISTRATION). To discontinue treatment in patients taking alprazolam tablets, the dosage should be reduced slowly in keeping with good medical practice. It is suggested that the daily dosage of alprazolam tablets be decreased by no more than 0. 5 mg every three days

Managing Xanax dependency involves a gradual tapering of the dosage under close supervision. The daily dosage of alprazolam should be decreased by no more than 0.5 mg every three days. This approach helps minimize the risk of withdrawal symptoms, which can range from mild to severe. Patients with a history of seizures, epilepsy, or substance abuse require careful monitoring during the tapering process. The goal is to reduce the dosage slowly to avoid precipitating withdrawal symptoms, including seizures, and to allow the patient to safely discontinue the medication 2.

From the Research

Managing Xanax Dependency

To manage Xanax (alprazolam) dependency, several strategies can be employed, including:

  • Gradual tapering of the medication to minimize withdrawal symptoms 3, 4, 5
  • Substitution with a longer-acting benzodiazepine, such as diazepam, to facilitate tapering 3, 5
  • Use of antidepressants to manage depressive symptoms that may occur during withdrawal 3
  • Psychological interventions, such as cognitive-behavioral therapy (CBT) and support groups, to address underlying issues and prevent relapse 3, 6

Withdrawal Symptoms and Management

Withdrawal from Xanax can result in a range of symptoms, including:

  • Rebound anxiety and insomnia 7
  • Full-blown withdrawal syndrome, characterized by symptoms such as sleep disturbance, irritability, and increased tension and anxiety 7
  • Seizures and psychotic reactions, particularly in cases of high-dose or abrupt withdrawal 4, 7 To manage these symptoms, a symptom-triggered taper approach can be effective, where the dose of Xanax is reduced in response to the severity of withdrawal symptoms 6

Treatment Approaches

Different treatment approaches can be used to manage Xanax dependency, including:

  • In-patient treatment, which can provide a supportive environment and close monitoring of withdrawal symptoms 5, 6
  • Out-patient treatment, which can be effective for individuals with less severe dependency and a strong support system 3
  • Combination of pharmacological and psychological interventions, which can address both the physical and psychological aspects of dependency 3, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Benzodiazepine withdrawal seizures and management.

The Journal of the Oklahoma State Medical Association, 2011

Research

The benzodiazepine withdrawal syndrome.

Addiction (Abingdon, England), 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.